Physicians Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-10,558
| Closed | -$628K | – | 117 |
|
2022
Q1 | $628K | Sell |
10,558
-300
| -3% | -$17.8K | 0.24% | 73 |
|
2021
Q4 | $788K | Sell |
10,858
-1,400
| -11% | -$102K | 0.29% | 69 |
|
2021
Q3 | $856K | Sell |
12,258
-100
| -0.8% | -$6.98K | 0.35% | 65 |
|
2021
Q2 | $851K | Sell |
12,358
-926
| -7% | -$63.8K | 0.35% | 65 |
|
2021
Q1 | $859K | Buy |
13,284
+334
| +3% | +$21.6K | 0.37% | 63 |
|
2020
Q4 | $754K | Sell |
12,950
-875
| -6% | -$50.9K | 0.36% | 62 |
|
2020
Q3 | $874K | Buy |
13,825
+132
| +1% | +$8.35K | 0.44% | 59 |
|
2020
Q2 | $1.05M | Buy |
13,693
+467
| +4% | +$35.9K | 0.58% | 49 |
|
2020
Q1 | $989K | Sell |
13,226
-300
| -2% | -$22.4K | 0.68% | 44 |
|
2019
Q4 | $879K | Sell |
13,526
-1,235
| -8% | -$80.3K | 0.48% | 61 |
|
2019
Q3 | $936K | Sell |
14,761
-850
| -5% | -$53.9K | 0.54% | 54 |
|
2019
Q2 | $1.06M | Buy |
15,611
+50
| +0.3% | +$3.38K | 0.62% | 51 |
|
2019
Q1 | $1.01M | Buy |
15,561
+610
| +4% | +$39.7K | 0.63% | 50 |
|
2018
Q4 | $935K | Sell |
14,951
-683
| -4% | -$42.7K | 0.68% | 43 |
|
2018
Q3 | $1.21M | Hold |
15,634
| – | – | 0.83% | 38 |
|
2018
Q2 | $1.11M | Sell |
15,634
-61
| -0.4% | -$4.32K | 0.83% | 39 |
|
2018
Q1 | $1.17M | Buy |
15,695
+950
| +6% | +$71.1K | 0.93% | 37 |
|
2017
Q4 | $1.06M | Sell |
14,745
-1,220
| -8% | -$87.4K | 0.81% | 39 |
|
2017
Q3 | $1.29M | Hold |
15,965
| – | – | 1.06% | 34 |
|
2017
Q2 | $1.13M | Buy |
15,965
+375
| +2% | +$26.5K | 0.96% | 37 |
|
2017
Q1 | $1.06M | Buy |
15,590
+3,975
| +34% | +$270K | 0.91% | 37 |
|
2016
Q4 | $950K | Sell |
11,615
-1,950
| -14% | -$159K | 0.78% | 41 |
|
2016
Q3 | $1.07M | Buy |
13,565
+2,184
| +19% | +$173K | 0.89% | 39 |
|
2016
Q2 | $949K | Buy |
11,381
+791
| +7% | +$66K | 0.83% | 39 |
|
2016
Q1 | $973K | Buy |
10,590
+1,535
| +17% | +$141K | 0.88% | 40 |
|
2015
Q4 | $916K | Buy |
+9,055
| New | +$916K | 0.85% | 38 |
|